Cargando…
CARF activates beta-catenin/TCF signaling in the hepatocellular carcinoma
Overactivation of Ras signaling is very common in the hepatocellular carcinoma (HCC) due to its constitutive active mutation, which makes it a big challenge to target Ras signaling. Therefore, identifying effectors downstream of Ras signaling would benefit the development of novel therapeutic strate...
Autores principales: | Fan, Xin, Ma, Xiaoyan, Cui, Lei, Dang, Shengchun, Qu, Jianguo, Zhang, Jianxin, Wang, Xuqing, Mao, Zhengfa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348329/ https://www.ncbi.nlm.nih.gov/pubmed/27829235 http://dx.doi.org/10.18632/oncotarget.13138 |
Ejemplares similares
-
YEATS4 promotes the tumorigenesis of pancreatic cancer by activating beta-catenin/TCF signaling
por: Jixiang, Chen, et al.
Publicado: (2017) -
Chemical biology reveals CARF as a positive regulator of canonical Wnt signaling by promoting TCF/β-catenin transcriptional activity
por: He, Xiaoli, et al.
Publicado: (2017) -
TFCP2 activates beta-catenin/TCF signaling in the progression of pancreatic cancer
por: Yuedi, Dai, et al.
Publicado: (2017) -
TM4SF1, a binding protein of DVL2 in hepatocellular carcinoma, positively regulates beta‐catenin/TCF signalling
por: Zhu, ChuanrRong, et al.
Publicado: (2019) -
NOP7 interacts with β-catenin and activates β-catenin/TCF signaling in hepatocellular carcinoma cells
por: Wu, Nan, et al.
Publicado: (2018)